OTC FILING WATCH · LIVEOfficial-source OTC filing intelligence
ISSUER DOSSIER · CIK 0001889791

INNOCAN PHARMA Corp (INNP, INNPF)

Issuer profile6 captured filing nodes

Business context

Core business: healthcare product development and commercialization. Products or assets: drug candidates, therapies or medical-device assets. Commercial model: research, regulatory progression and commercialization.

First captured2025-08-04
Latest filingF-1/A · 2026-04-03
Registration path0 initial filings · 6 amendments

What to watch next

Compare the next amendment against the current filing, then monitor for EFFECT or 424B. Material offering terms can change between amendments.

Latest captured filing: F-1/A · 2026-04-03 · 118 days ago.

Official filing timeline

  1. F-1/A · official filing

    INNOCAN PHARMA Corp (INNP, INNPF)

  2. F-1/A · official filing

    INNOCAN PHARMA Corp (INNP, INNPF)

  3. F-1/A · official filing

    INNOCAN PHARMA Corp (INNP, INNPF)

  4. F-1/A · official filing

    INNOCAN PHARMA Corp (INNP, INNPD)

  5. F-1/A · official filing

    INNOCAN PHARMA Corp (INNP, INNPF)

  6. F-1/A · official filing

    INNOCAN PHARMA Corp (INNP, INNPF)

Open latest official filing →